Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FL0FA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,412
Award facts
- Contract value 100% obligated
- $14,412.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 300 mg/2 mL pens on December 1, 2025, with a ceiling value of $14,412.08 and an ultimate completion date of December 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is listed as the company's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and other allergic conditions, and this delivery supports federal medical supply requirements for military and potentially veteran healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a significant $999,999,999 prime IDC with DLA Troop Support Medical (designation SPE2DX) through December 2026, which serves as the underlying contract vehicle for this delivery order. The company maintains an extensive federal contract portfolio delivering comprehensive pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order represents a routine fulfillment under the broader pharmaceutical prime vendor agreement that enables flexible procurement of critical medical commodities for military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FL0FA?
SPE2DR26FL0FA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FL0FA worth?
The government has obligated $14,412 on SPE2DR26FL0FA.
Is contract SPE2DR26FL0FA an order under another contract?
Yes. SPE2DR26FL0FA is a delivery order under SPE2DR25D3401, an indefinite delivery contract.
Was contract SPE2DR26FL0FA competed?
The extent of competition for SPE2DR26FL0FA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award